4Larsson B, Svardsudd k, Welin L, et al. Abdominal adipose tissue distribution, obesity, and risk o cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br MedJ,1984,288:1401-1404.
5Nkamura T, Tokunaga K, Shimomura I, et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerrosis , 1994,107 : 239-246.
6Marceau P, Biron S, Hould FS, et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab, 1999,84 : 1513-1517.
7Banerji MA, Buckley MC, Chaiken RI, et al. Liver fat,serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int J Obes,1995,19:846-850.
8Scatarige JC, Scott WW, Donovan PJ, et al. Fatty infiltration of the liver: ultrasonographic and computed tomographic correlation. J Ultrasound Med, 1984, 3:9-14.
9James O, Day C. Non-alcoholic steatohepatitis another disease of affluence. Lancet, 1999,353: 1634-1636.
10Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease a feature of the metabolic syndrome.Diabetes, 2001,50 : 1844-1850.
6Kusunoki M, Tsutsumi K, Inoue Y, et al. Lipoprotein lipaseactivator NO 1886 improves fatty liver caused by high fatfeeding in streptozotocin induced diabetic rats[ J]. Metabolism ,2004,53:260 -263.
7Dormelly K L, Smith C I, Schwarzenberg S J, et al. Sources of fatty acids stored in liver and secreted vialipo proteins in patients with nonal- coholic fatty hverdisease[ J]. J Clin Invest, 2005, 115: 1343.
8Bedogni G, Miglioli L, Masutti F, et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study[J]. Hepatology, 2005,42: 44.
9Dixon JB, Bhathal PS, O Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severe- ly obese[J]. Gastroenterology, 2001, 121: 91.
10Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease [ J ]. Hepatology, 2005, 41 : 1313.
